China · Delayed Price · Currency is CNY Cofoe Medical Technology Statistics
Total Valuation
SHE:301087 has a market cap or net worth of CNY 11.70 billion. The enterprise value is 9.55 billion.
| Market Cap | 11.70B |
| Enterprise Value | 9.55B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
SHE:301087 has 227.13 million shares outstanding. The number of shares has increased by 2.25% in one year.
| Current Share Class | 200.13M |
| Shares Outstanding | 227.13M |
| Shares Change (YoY) | +2.25% |
| Shares Change (QoQ) | +5.65% |
| Owned by Insiders (%) | 10.24% |
| Owned by Institutions (%) | 14.70% |
| Float | 102.03M |
Valuation Ratios
The trailing PE ratio is 28.34 and the forward PE ratio is 24.49. SHE:301087's PEG ratio is 1.44.
| PE Ratio | 28.34 |
| Forward PE | 24.49 |
| PS Ratio | 2.95 |
| PB Ratio | 2.10 |
| P/TBV Ratio | 2.40 |
| P/FCF Ratio | 26.56 |
| P/OCF Ratio | 19.29 |
| PEG Ratio | 1.44 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.34, with an EV/FCF ratio of 21.66.
| EV / Earnings | 23.48 |
| EV / Sales | 2.41 |
| EV / EBITDA | 16.34 |
| EV / EBIT | 24.49 |
| EV / FCF | 21.66 |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.63 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 1.49 |
| Debt / FCF | 1.97 |
| Interest Coverage | 21.22 |
Financial Efficiency
Return on equity (ROE) is 7.87% and return on invested capital (ROIC) is 10.40%.
| Return on Equity (ROE) | 7.87% |
| Return on Assets (ROA) | 3.53% |
| Return on Invested Capital (ROIC) | 10.40% |
| Return on Capital Employed (ROCE) | 6.84% |
| Weighted Average Cost of Capital (WACC) | 7.18% |
| Revenue Per Employee | 780,079 |
| Profits Per Employee | 80,001 |
| Employee Count | 5,081 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 2.49 |
Taxes
In the past 12 months, SHE:301087 has paid 63.38 million in taxes.
| Income Tax | 63.38M |
| Effective Tax Rate | 13.48% |
Stock Price Statistics
The stock price has increased by +39.27% in the last 52 weeks. The beta is 0.60, so SHE:301087's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +39.27% |
| 50-Day Moving Average | 51.46 |
| 200-Day Moving Average | 51.47 |
| Relative Strength Index (RSI) | 61.94 |
| Average Volume (20 Days) | 2,744,936 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301087 had revenue of CNY 3.96 billion and earned 406.48 million in profits. Earnings per share was 1.94.
| Revenue | 3.96B |
| Gross Profit | 2.16B |
| Operating Income | 389.69M |
| Pretax Income | 470.25M |
| Net Income | 406.48M |
| EBITDA | 507.86M |
| EBIT | 389.69M |
| Earnings Per Share (EPS) | 1.94 |
Balance Sheet
The company has 3.06 billion in cash and 867.65 million in debt, with a net cash position of 2.19 billion or 9.66 per share.
| Cash & Cash Equivalents | 3.06B |
| Total Debt | 867.65M |
| Net Cash | 2.19B |
| Net Cash Per Share | 9.66 |
| Equity (Book Value) | 5.56B |
| Book Value Per Share | 24.17 |
| Working Capital | 2.87B |
Cash Flow
In the last 12 months, operating cash flow was 606.70 million and capital expenditures -166.12 million, giving a free cash flow of 440.59 million.
| Operating Cash Flow | 606.70M |
| Capital Expenditures | -166.12M |
| Depreciation & Amortization | 118.16M |
| Net Borrowing | 14.96M |
| Free Cash Flow | 440.59M |
| FCF Per Share | 1.94 |
Margins
Gross margin is 54.38%, with operating and profit margins of 9.83% and 10.26%.
| Gross Margin | 54.38% |
| Operating Margin | 9.83% |
| Pretax Margin | 11.86% |
| Profit Margin | 10.26% |
| EBITDA Margin | 12.81% |
| EBIT Margin | 9.83% |
| FCF Margin | 11.12% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 3.28%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 3.28% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 92.32% |
| FCF Payout Ratio | 92.79% |
| Buyback Yield | -2.25% |
| Shareholder Yield | 1.02% |
| Earnings Yield | 3.47% |
| FCF Yield | 3.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHE:301087 is 65.28, which is 18.82% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 65.28 |
| Price Target Difference | 18.82% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 22.70% |
| EPS Growth Forecast (3Y) | 27.14% |
Stock Splits
The last stock split was on May 20, 2022. It was a forward split with a ratio of 1.3000013.
| Last Split Date | May 20, 2022 |
| Split Type | Forward |
| Split Ratio | 1.3000013 |
Scores
SHE:301087 has an Altman Z-Score of 4.37 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.37 |
| Piotroski F-Score | 6 |